Table 2.

Unadjusted (bivariate) linear regression analyses of factors associated with financial toxicity (FACIT-COST) and psychological distress (PHQ-4).

Predictor	Category (vs. reference)	FACIT-COST β	p-value	PHQ-4 β	p-value
Age (years)	Per 1-year increase	0.05	0.64	−0.01	0.87
Gleason risk group	Intermediate vs. High	5.59	0.002	−1.92	0.004
	Low vs. High	8.54	0.029	−1.86	0.202
Insurance type	Private vs. No coverage	7.36	0.008	−1.20	0.254
	Public vs. No coverage	0.39	0.88	0.59	0.54
Treatment modality	Local vs. Combined	5.29	0.008	−1.55	0.039
	Systemic only vs. Combined	−2.72	0.22	0.28	0.74
Actual treatment coverage	None vs. Full	−12.00	< 0.001	2.11	0.016
	Partial vs. Full	−8.85	< 0.001	2.04	0.011
Treatment disruption	Interruption vs. Delay	2.87	0.33	−1.11	0.33
	None vs. Delay	13.40	< 0.001	−4.53	< 0.001
Monthly household income	Low vs. High	−17.70	< 0.001	5.51	< 0.001
	Medium vs. High	−7.57	< 0.001	2.22	0.002
Comorbidities	Yes vs. No	−0.81	0.68	0.56	0.43

(FACIT-COST and PHQ-4 scores analyzed as continuous outcomes. β coefficients represent unadjusted associations relative to reference categories.) FACIT-COST, functional assessment of chronic illness therapy–cost; PHQ-4, patient health questionnaire-4.